Загрузка...
Osteoprotegerin and Mortality in Type 2 Diabetic Patients
OBJECTIVE: Plasma osteoprotegerin (OPG) is an emerging strong and independent predictor of cardiovascular disease (CVD) in high-risk populations. OPG is a bone-related glycopeptide produced by vascular smooth muscle cells, and increased plasma OPG levels may reflect arterial vascular damage. We aime...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Diabetes Association
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2992191/ https://ncbi.nlm.nih.gov/pubmed/20929997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc10-0858 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|